Skip to main content
. 2020 Jul;14(2):111–119. doi: 10.5704/MOJ.2007.020

Table II.

Factors associated with pre-operative CKD

Descriptor Pre-operative CKD N=40 No Pre-operative CKD N=163 Univariate P value Multivariate Odds Ratio 95% Confidence Interval P value
Gender (Male, Female) 10, 30 24, 139 0.119 2.424 0.877-6.705 0.088
Age (years) (mean±SD, range) 73.9±9.7, 43-90 63.2±10.1, 37-87 <0.001 1.114 1.065-1.165 <0.001
BMI (kg/m2) (mean±SD, range) 24.5±3.7, 17.7-34.7 24.2±4.2, 16.0-42.7 0.736
Pre-operative NSAIDs use
 Yes 12 (30%) 43 (26%) 0.644
 No 28 (70%) 120 (74%)
Pre-operative ACEi/ARB use
 Yes 14 (35%) 36 (28%) 0.089 1.197 0.494-2.897 0.690
 No 26 (65%) 127 (78%)
Pre-operative diuretics use
 Yes 6 (15%) 2 (1%) <0.001 6.902 1.191-40.006 0.031
 No 34 (85%) 161 (99%)
Pre-operative statin use
 Yes 12 (30%) 27 (17%) 0.053 1.363 0.538-3.455 0.514
 No 28 (70%) 136 (83%)
History of diabetes mellitus
 Yes 7 (18%) 13 (8%) 0.07 0.973 0.277-3.418 0.966
 No 33 (82%) 150 (92%)

*CKD, chronic kidney disease; SD, standard deviation; BMI, body mass index; NSAIDs, nonsteroidal anti-inflammatory drugs; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-II receptor blocker.